Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akebia Therapeutics (AKBA) Change in Inventory: 2018-2024

Historic Change in Inventory for Akebia Therapeutics (AKBA) over the last 7 years, with Dec 2024 value amounting to $28.4 million.

  • Akebia Therapeutics' Change in Inventory fell 1365.87% to -$6.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.2 million, marking a year-over-year decrease of 55.17%. This contributed to the annual value of $28.4 million for FY2024, which is 1017.27% up from last year.
  • According to the latest figures from FY2024, Akebia Therapeutics' Change in Inventory is $28.4 million, which was up 1,017.27% from $2.5 million recorded in FY2023.
  • Akebia Therapeutics' 5-year Change in Inventory high stood at $28.4 million for FY2024, and its period low was -$19.1 million during FY2022.
  • For the 3-year period, Akebia Therapeutics' Change in Inventory averaged around $4.0 million, with its median value being $2.5 million (2023).
  • As far as peak fluctuations go, Akebia Therapeutics' Change in Inventory plummeted by 176.51% in 2022, and later soared by 1,017.27% in 2024.
  • Akebia Therapeutics' Change in Inventory (Yearly) stood at -$6.2 million in 2020, then spiked by 504.79% to $24.9 million in 2021, then tumbled by 176.51% to -$19.1 million in 2022, then spiked by 113.32% to $2.5 million in 2023, then skyrocketed by 1,017.27% to $28.4 million in 2024.